home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

5th Annual Genome Editing Congress

 
  August 01, 2019  
     
 
Oxford Global, Novotel London West, 1 Shortlands, Hammersmith International Ctre, Hammersmith, London, UK W6 8DR
07 - 08 November 2019


Over 600 senior-level delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.

Over 20 case studies and presentations focused on the latest developments in gene editing techniques and case studies on the therapeutic applications of genome editing technologies.

Including 2 Interactive Streams:

  • Genome Editing Techniques and Technologies
  • Therapeutic Applications of Genome Editing

View Agenda: https://bit.ly/2s1kWe7

Co-located with the highly established 11th Annual Next Generation Sequencing & Clinical Diagnostics Congress7th Annual Single Cell Analysis Congress, 2nd Synthetic Biology Congress and the Digital PCR Congress.

For more information contact b.copeman@oxfordglobal.co.uk.

Go Social: Join our Genomics Networking Group on LinkedIn, follow us on Twitter @xgenseq & join the conversation at #GENSERIESUK19


2019 Live Webinar
Applications of CRISPR/Cas9 in studying disease mechanisms
Presented by Kristine Freude, Associate Professor & Director of BrainStem - Center for Excellence in Neuroscience, University of Copenhagen and Yonglun Luo, Group Leader, Aarhus University
Tuesday October 1st, 2019 at 10:00am BST
Register for Free: 
https://bit.ly/2JFbVA7

Benefits of Attending

  • An overview of the current available tools (repair, knockin, activation and repression of disease genes)
  • An assessment of the disease modeling tools compared to patient readouts
  • Exploration & Evaluation: How good are the model systems? What are we missing?
 
 
Organized by: Oxford Global
Invited Speakers:

Barry Rosen, Vice President and Senior Principal Scientist
AstraZeneca

Achim Kless, Scientific Director
Grünenthal GmbH

Aaron Cheng, Head, Discovery Genome Editing
GlaxoSmithKline

For the full line-up of speakers, please view our agenda: https://bit.ly/2s1kWe7

 

 
Deadline for Abstracts: N/A
 
Registration: For details on how to register, please download our free agenda: https://bit.ly/2s1kWe7
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.